Type I Interferon Signaling Exacerbates Chlamydia muridarum Genital Infection in a Murine Model
Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice gene...
Saved in:
Published in | Infection and Immunity Vol. 76; no. 10; pp. 4642 - 4648 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Society for Microbiology
01.10.2008
American Society for Microbiology (ASM) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Type I interferons (IFNs) induced during in vitro chlamydial infection exert bactericidal and immunomodulatory functions. To determine the precise role of type I IFNs during in vivo chlamydial genital infection, we examined the course and outcome of Chlamydia muridarum genital infection in mice genetically deficient in the receptor for type I IFNs (IFNAR⁻/⁻ mice). A significant reduction in chlamydial shedding and duration of lower genital tract infection was observed in IFNAR⁻/⁻ mice in comparison to the level of chlamydial shedding and duration of infection in wild-type (WT) mice. Furthermore, IFNAR⁻/⁻ mice developed less chronic oviduct pathology in comparison to that in WT mice. Compared to the WT, IFNAR⁻/⁻ mice had a greater number of chlamydial-specific T cells in their iliac lymph nodes 21 days postinfection. IFNAR⁻/⁻ mice also exhibited earlier and enhanced CD4 T-cell recruitment to the cervical tissues, which was associated with increased expression of CXCL9 in the genital secretions of IFNAR⁻/⁻ mice, but not with expression of CXCL10, which was reduced in the genital secretions of IFNAR⁻/⁻ mice. These data suggest that type I IFNs exacerbate C. muridarum genital infection through an inhibition of the chlamydial-specific CD4 T-cell response. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Corresponding author. Mailing address: Division of Pediatric Infectious Diseases, Arkansas Children's Hospital Research Institute, 1120 Marshall Street, Room 2052, Little Rock, AR 72202. Phone: (501) 364-2479. Fax: (501) 364-2403. E-mail: nagarajanuma@uams.edu Present address: Department of Pediatrics, University of Pittsburgh Medical Center, Pittsburgh, PA 15213. Editor: B. A. McCormick |
ISSN: | 0019-9567 1098-5522 |
DOI: | 10.1128/IAI.00629-08 |